Table 3.

Gains shared by at least three samples

Patients	Gain/loss	Genes
1, 2, 6	Gain 2p24.3	TRIB2 (oncogene that inactivates the transcription factor C/EBPalpha and causes acute myelogenous leukemia)
2, 4, 6	Gain 3q29	MFI2 (cell-surface glycoprotein found on melanoma cells)
2, 4, 6	Gain 10q11.21	RET (Proto-oncogene. Diseases associated include familial papillary thyroid carcinoma)
2, 4, 6	Gain 12q13.12	WNT1 (secreted signaling protein. Implicated in oncogenesis), DDN (promotes apoptosis of kidney glomerular podocytes), PRKAG1 (Regulatory subunit of the AMP-activated protein kinase)
1, 2, 6	Gain 21q22.12	RUNX1 (involved in the development of normal hematopoiesis. Diseases associated include familial platelet disorder with associated myeloid malignancy)
2, 4, 6	Gain Xq21.1	BRWD3 (chromatin-modifying function. Diseases associated include chronic lymphocytic leukemia)
2, 4, 6	Gain Xq25	GRIA3 (receptor for glutamate)
2, 4, 6	Gain Xq25	XIAP (oncogene. Diseases associated include chronic neutrophilic leukemia)